Cetuximab

Celecoxib

Celecoxib

Celecoxib (SC 58635) GMP Like is a GMP-class Celecoxib. Celecoxib, a selective non-steroidal anti-inflammatory drug (NSAID), is a selective COX-2 inhibitor with an IC50 of 40 nM.

An anti-inflammatory compound from the diaryl heterocycle class that selectively inhibits COX-2 (IC50s = 22.9 and 0.

An anti-inflammatory compound from the diaryl heterocycle class that selectively inhibits COX-2 (IC50s = 22.9 and 0.

An anti-inflammatory compound from the diaryl heterocycle class that selectively inhibits COX-2 (IC50s = 22.9 and 0.

InformationCelecoxib (SC 58635) is a selectiveCOX-2inhibitor withIC50of 40 nM in Sf9 cells.In vitroCelecoxib shows low sensitivity against COX-1 with IC50 of 15 μM. Celecoxib shows an anti-proliferative effect on nasopharyngeal carcinoma (NPC) cell

Synonyms: Mordant Blue 14 CI 51050  Purity Limit: Dye content: &ge 80% CAS No.: 1562-90-9 Molecular Formula: C17H18N3O4Cl Molecular Weight: 363.

Cemiplimab is a monoclonal IgG4 antibody with high affinity for programmed death receptor-1 (PD-1) that blocks PD-1/PD-L1 mediated T cell inhibition. It is commonly used in squamous cell skin cancer research.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin

Cemiplimab is a monoclonal IgG4 antibody with high affinity for programmed death receptor-1 (PD-1) that blocks PD-1/PD-L1 mediated T cell inhibition. It is commonly used in squamous cell skin cancer research.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin

Cemiplimab is a monoclonal IgG4 antibody with high affinity for programmed death receptor-1 (PD-1) that blocks PD-1/PD-L1 mediated T cell inhibition. It is commonly used in squamous cell skin cancer research.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin

Cemiplimab is a monoclonal IgG4 antibody with high affinity for programmed death receptor-1 (PD-1) that blocks PD-1/PD-L1 mediated T cell inhibition. It is commonly used in squamous cell skin cancer research.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin